VANCOUVER, FEB 26TH 2020, 6:00AM

EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) today reports the Company’s consolidated interim financial results for the first quarter ended December 31, 2019.

EnWave’s interim consolidated financial statements and MD&As are available on SEDAR at www.sedar.com and on the Company’s website www.enwave.net.

أبرز الملامح المالية الرئيسية للربع الأول (معبراً عنها بـ '000)

• Reported revenue for Q1 2020 of $8,609 compared to $7,806 for Q1 2019, an increase of $803 or 10%. During Q1 2020 we had the highest number of large-scale Radiant Energy Vacuum (“REV^TM”) machines in fabrication at one point in time for the Company. Moon Cheese^® sales in the quarter were downwardly affected due to excess inventory in the club channel that was previously sold in Q4 2019 for the Most Valuable Member (“MVM”) program in Costco; however, improved distribution was achieved in other channels and repeat sales were strong overall.
• Achieved gross profit of $3,196 for Q1 2020 compared to $3,037 for Q1 2019, an increase of $159. Gross margin held steady at 37% in Q1 2020 compared to 39% for Q1 2019. The sales mix shifted in the quarter with more revenue from machine sales, and our cost absorption improved with a larger number of machines being fabricated concurrently. EnWave expects the gross margin on machine sales to improve in coming quarters due to the implementation of a revised pricing schedule.
• Consolidated net loss after taxes was $1,426 for Q1 2020 compared to a net loss of $15 for Q1 2019, an increase of $1,411. Adjusted EBITDA^(*) was negative $743 for Q1 2020 compared to Adjusted EBITDA^(*) of positive $1,163 for Q1 2019, a decrease of $1,906. We continued to make significant investments to establish a high-quality sales and marketing infrastructure at NutraDried to make Moon Cheese^® a category leading brand.
• Invested in S&M expenses of $1,943 in Q1 2020 compared to $976 in Q1 2019. We rebranded Moon Cheese^® and relaunched the brand with new packaging, a new website and new package sizes. We expanded our sales infrastructure by adding to our team of professionals that are located geographically around the U.S. with a focus on sales growth in diversified channels. We also hired a Chief Marketing Officer to develop and execute a marketing strategy to drive improved consumer awareness and trial. These S&M investments are anticipated to create sustained future value through increased distribution and new channel penetration.
• Maintained a strong working capital surplus of $25,093 and a debt-free balance sheet, providing a robust foundation for future company growth including, REV™ machine fabrication, royalty generation and Moon Cheese^®

Significant Accomplishments:

• Re-launched the Moon Cheese^® brand with world-class packaging, branding, consumer messaging and digital assets. Moon Cheese^® is now available in 10oz, 2oz and 1oz package sizes that have been customized to suit specific channels of distribution. Along with the new branding, we launched two new flavors: Bacon Cheddar and Garlic Parmesan. The new flavors were chosen based on the results of extensive consumer testing and research. At the beginning of 2018, Moon Cheese^® was offered in five flavor/size variations, but has now been expanded to fifteen flavor/size formats to optimize our product portfolio to suit target customer preferences.
• Signed six new royalty-bearing commercial license agreements in Q1 2020 through to the date of this report. Three of these license agreements were in the food products vertical and three were in the cannabis vertical. The new royalty-bearing licenses and REV^TM machine sales to the food vertical in Q1 include:
• Signed a royalty-bearing commercial license agreement with Pacifico Snacks S.A.S. (“Pacifico Snacks”) and received a purchase order for a 10kW machine. Pacifico Snacks is a woman-owned Columbian producer of natural snacks with distribution to specialty retailers and for private label in North America. Pacifico plans to launch mango, pineapple and banana products using REV^TM in 2020.
• Signed a royalty-bearing commercial license agreement with KL Ballantyne Pty Ltd (“Ballantyne”), a leading family-owned Australian dairy producer. Ballantyne purchased a 10kW REV™ machine to initiate commercial production of several dairy ingredients and products developed for B2B sales in Australia and internationally.
• Signed a royalty-bearing commercial license agreement with Responsible Foods ehf (“Responsible Foods”) for the dehydration of premium Icelandic raw materials including dairy, seafood, meat, microalgae and seaweed. Responsible Foods is a start-up snack food company focused on better-for-you snack and ingredient offerings using REV^TM
• Secured a second purchase order from Fresh Business Consulting S.L. (“Fresh Business”) for a 100kW large-scale REV™ processing line. The purchase order represents Fresh Business’ second REV™ machine for Peru and the scale-up of Fresh Business’ royalty-bearing processing capacity for the meaningful commercial production of premium dried fruit and vegetable products.
• Continued to broaden the global sales of REV^TM drying machines for cannabis. At the beginning of 2019, EnWave had two cannabis royalty partners licensed to use the EnWave technology – both in Canada.  EnWave now has licensed royalty partners for cannabis and hemp drying in the United States, New Zealand, Switzerland and Australia, which includes the following licenses secured in Q1:
• Signed a royalty-bearing commercial license agreement with Helius Therapeutics Ltd. (“Helius”), New Zealand’s largest licensed medical cannabis company. Helius purchased a 10kW REV™ machine to initiate commercial dying of cannabis in New Zealand in 2020.
• Signed a royalty-bearing commercial license agreement with Cann Group Limited (“Cann Group”), Australia’s first Medical Cannabis Cultivation Licensee. Cann Group purchased a 10kW REV™ machine to initiate commercial production in 2020.
• Signed a royalty-bearing commercial license agreement and equipment lease agreement with a Medical Cannabidiol (“CBD”) Company in Switzerland. The Swiss CBD company has the non-exclusive right to use REV^TM technology to dehydrate medicinal-grade hemp for cannabidiol extraction and will initially use a leased 10kW REV™ machine for commercial production.
• Signed a technology license and joint development agreement (the “JDA”) with GEA Lyophil GmbH, a global manufacturer and marketer of freeze-dry units for the pharmaceutical and biotech industries, to accelerate the potential commercialization of REV™ technology in the pharmaceutical industry.

Grant of Stock Options and RSRs to New Independent Director:

On February 12, 2020, the Company appointed Mr. Patrick Turpin as a new independent director to the Company’s Board of Directors. Mr. Turpin is a seasoned executive in the consumer-packaged goods vertical and brings over 30 years of experience in the space, including as co-founder and former President of Popchips Inc. and as a former Vice President at Costco.

The Company has granted Mr. Turpin an aggregate of 150,000 incentive stock options, subject to the terms of the Company’s Stock Option Plan (the “Plan”), that are exercisable at the last closing price of the Company’s common shares on the TSX Venture Exchange (“TSXV”) on February 26, 2020. The incentive stock options are exercisable for a term of five years expiring on February 26, 2025 and will vest in accordance to the provisions set out in the Plan, or as otherwise required by the TSXV. The Company also granted Mr. Turpin an aggregate of 20,000 Restricted Share Rights (“RSRs”) pursuant to the Company’s Restricted Share Rights Plan. The RSRs granted will vest three years from the date of the award.

^(*) Non-IFRS Financial Measures:

Adjusted EBITDA is not a measure of financial performance under IFRS. We define Adjusted EBITDA as earnings before deducting amortization and depreciation, stock-based compensation, foreign exchange gain or loss, finance expense or income, income tax expense and non-recurring restructuring and impairment charges. This measure is not necessarily comparable to similarly titled measures used by other companies and should not be construed as an alternative to net income or cash flow from operating activities as determined in accordance with IFRS. Please refer to the discussion included in the Company’s interim MD&A for the three months ended December 31, 2019.

DOWNLOAD THIS RELEASE

نبذة عن EnWave

قامت شركة EnWave Corporation، وهي شركة تكنولوجيا متقدمة مقرها فانكوفر، بتطوير تقنية Radiant Energy Vacuum ("REV™") - وهي طريقة مبتكرة مسجلة الملكية لتجفيف المواد العضوية بدقة. وقد تم إثبات الجدوى التجارية لتكنولوجيا REV™، وهي تنمو بسرعة في العديد من قطاعات السوق في قطاعات الأغذية والقنب القانوني والأدوية. وتتمثل استراتيجية شركة EnWave في توقيع تراخيص تجارية ذات حقوق ملكية مع رواد الصناعة في قطاعات متعددة لاستخدام تقنية REV™. وقد وقّعت الشركة أكثر من عشرين ترخيصًا تجاريًا خاضعًا للإتاوات حتى الآن، مما يفتح ثمانية قطاعات متميزة في السوق لتسويق منتجات جديدة ومبتكرة. وبالإضافة إلى هذه التراخيص، قامت شركة EnWave بتأسيس شركة شراكة ذات مسؤولية محدودة، NutraDried LLP، لتطوير وتصنيع وتسويق وبيع منتجات الوجبات الخفيفة من الجبن الطبيعي بالكامل في الولايات المتحدة تحت العلامة التجارية Moon Cheese®.

قدمت EnWave تقنية REV™ كمعيار جديد للتجفيف في قطاعي الأغذية والمواد البيولوجية: أسرع وأرخص من التجفيف بالتجميد، مع جودة منتج نهائي أفضل من التجفيف بالهواء أو التجفيف بالرذاذ. ولدى EnWave حاليًا ثلاث منصات تجارية لـ REV™:
1. nutraREV®الذي يستخدم في صناعة الأغذية لتجفيف المنتجات الغذائية بسرعة وبتكلفة منخفضة، مع الحفاظ على مستويات عالية من التغذية والطعم والملمس واللون؛ و
2. quantaREV®الذي يستخدم للتجفيف المستمر ذي الحجم الكبير في درجات الحرارة المنخفضة.

يتوفر المزيد من المعلومات حول EnWave على www.enwave.net.

شركة EnWave
الدكتور تيم دورانس
الرئيس والمدير التنفيذي

لمزيد من المعلومات:
جون بودريسكي، رئيس مجلس الإدارة التنفيذي على الرقم +1 (416) 930-0914 (416) 930-0914
البريد الإلكتروني: jbudreski@enwave.net

برنت تشارلتون، نائب الرئيس الأول للمبيعات وتطوير الأعمال على الرقم +1 (778) 378-378-9616
البريد الإلكتروني: bcharleton@enwave.net

ديبورا هونيج، تطوير الشركات، أديلايد كابيتال ماركتس على الرقم + 1 (647) 203-8793
البريد الإلكتروني: dhonig@enwave.net

الملاذ الآمن لبيانات المعلومات التطلعية: قد يحتوي هذا البيان الصحفي على معلومات تطلعية مبنية على توقعات الإدارة وتقديرات وتوقعات الإدارة. إن جميع البيانات التي تتناول التوقعات أو التوقعات حول المستقبل، بما في ذلك البيانات المتعلقة باستراتيجية الشركة للنمو، وتطوير المنتجات، والمكانة السوقية، والنفقات المتوقعة، والنفقات المتوقعة، وأوجه التآزر المتوقعة بعد الإغلاق، هي بيانات تطلعية. جميع ادعاءات الطرف الثالث المشار إليها في هذا البيان غير مضمونة الدقة. جميع إشارات الأطراف الثالثة إلى معلومات السوق الواردة في هذا البيان الصحفي غير مضمونة الدقة لأن الشركة لم تقم بإجراء البحث الأساسي الأصلي. هذه البيانات ليست ضمانة للأداء المستقبلي وتنطوي على عدد من المخاطر والشكوك والافتراضات. وعلى الرغم من أن الشركة حاولت تحديد العوامل المهمة التي يمكن أن تتسبب في اختلاف النتائج الفعلية بشكل جوهري، إلا أنه قد تكون هناك عوامل أخرى تتسبب في أن تكون النتائج غير متوقعة أو مقدرة أو مقصودة. لا يمكن أن يكون هناك أي ضمان بأن مثل هذه البيانات ستكون دقيقة، حيث يمكن أن تختلف النتائج الفعلية والأحداث المستقبلية بشكل جوهري عن تلك المتوقعة في مثل هذه البيانات. وبناءً على ذلك، يجب على القراء عدم الاعتماد بشكل غير مبرر على البيانات التطلعية.

لا تقبل بورصة TSX Venture Exchange ولا مزود الخدمات التنظيمية (كما هو معرّف في سياسات بورصة TSX Venture Exchange) المسؤولية عن كفاية أو دقة هذا البيان.